Literature DB >> 16545769

Quantification of malonyl-coenzyme A in tissue specimens by high-performance liquid chromatography/mass spectrometry.

Paul E Minkler1, Janos Kerner, Takhar Kasumov, William Parland, Charles L Hoppel.   

Abstract

We present a validated high-performance liquid chromatography/mass spectrometry (HPLC/MS) method for the quantification of malonyl-coenzyme A (CoA) in tissues. The assay consists of extraction of malonyl-CoA from tissue using 10% trichloroacetic acid, isolation using a reversed-phase solid-phase extraction column, HPLC separation, and detection using electrospray MS. Quantification was performed using an internal standard ([(13)C(3)]malonyl-CoA) and multiple-point standard curves from 50 to 1000pmol. The procedure was validated by performing recovery, accuracy, and precision studies. Recoveries of malonyl-CoA were determined to be 28.8+/-0.9, 48.5+/-1.8, and 44.7+/-4.4% (averages+/-SD, n=5) for liver, heart, and skeletal muscle, respectively. Accuracy was demonstrated by the addition of known amounts of malonyl-CoA to tissue samples. The malonyl-CoA detected was compared with the malonyl-CoA added, and the resulting relationships were linear with slopes and regression coefficients equal to 1. Precision was demonstrated by repetitive analysis of identical samples. These showed a within-run variation between 5 and 11%, and the interbatch repeatability was essentially the same. This procedure was then applied to rat liver, heart, and skeletal muscle, where the malonyl-CoA contents were found to be 1.9+/-0.6, 1.3+/-0.4, and 0.7+/-0.2nmol/g wet weight, respectively, for these tissues. This analytical approach can be extended to the quantification of other acyl-CoA species with no significant modification.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16545769     DOI: 10.1016/j.ab.2006.02.015

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  17 in total

1.  Mice lacking δ-opioid receptors resist the development of diet-induced obesity.

Authors:  Traci A Czyzyk; Amparo Romero-Picó; John Pintar; Jaime H McKinzie; Matthias H Tschöp; Michael A Statnick; Ruben Nogueiras
Journal:  FASEB J       Date:  2012-05-16       Impact factor: 5.191

2.  Assessment of heterologous butyrate and butanol pathway activity by measurement of intracellular pathway intermediates in recombinant Escherichia coli.

Authors:  Curt R Fischer; Hsien-Chung Tseng; Mitchell Tai; Kristala L J Prather; Gregory Stephanopoulos
Journal:  Appl Microbiol Biotechnol       Date:  2010-07-13       Impact factor: 4.813

3.  SILEC: a protocol for generating and using isotopically labeled coenzyme A mass spectrometry standards.

Authors:  Sankha S Basu; Ian A Blair
Journal:  Nat Protoc       Date:  2011-12-08       Impact factor: 13.491

4.  LC-quadrupole/Orbitrap high-resolution mass spectrometry enables stable isotope-resolved simultaneous quantification and ¹³C-isotopic labeling of acyl-coenzyme A thioesters.

Authors:  Alexander J Frey; Daniel R Feldman; Sophie Trefely; Andrew J Worth; Sankha S Basu; Nathaniel W Snyder
Journal:  Anal Bioanal Chem       Date:  2016-03-11       Impact factor: 4.142

5.  Fatty acid chain elongation in palmitate-perfused working rat heart: mitochondrial acetyl-CoA is the source of two-carbon units for chain elongation.

Authors:  Janos Kerner; Paul E Minkler; Edward J Lesnefsky; Charles L Hoppel
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

6.  Novel isolation procedure for short-, medium-, and long-chain acyl-coenzyme A esters from tissue.

Authors:  Paul E Minkler; Janos Kerner; Stephen T Ingalls; Charles L Hoppel
Journal:  Anal Biochem       Date:  2008-02-29       Impact factor: 3.365

7.  Novel approach in LC-MS/MS using MRM to generate a full profile of acyl-CoAs: discovery of acyl-dephospho-CoAs.

Authors:  Qingling Li; Shenghui Zhang; Jessica M Berthiaume; Brigitte Simons; Guo-Fang Zhang
Journal:  J Lipid Res       Date:  2013-12-23       Impact factor: 5.922

8.  Identification of a novel malonyl-CoA IC(50) for CPT-I: implications for predicting in vivo fatty acid oxidation rates.

Authors:  Brennan K Smith; Christopher G R Perry; Timothy R Koves; David C Wright; Jeffrey C Smith; P Darrell Neufer; Deborah M Muoio; Graham P Holloway
Journal:  Biochem J       Date:  2012-11-15       Impact factor: 3.857

9.  Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity.

Authors:  Kyle L Hoehn; Nigel Turner; Michael M Swarbrick; Donna Wilks; Elaine Preston; Yuwei Phua; Himani Joshi; Stuart M Furler; Mark Larance; Bronwyn D Hegarty; Simon J Leslie; Russell Pickford; Andrew J Hoy; Edward W Kraegen; David E James; Gregory J Cooney
Journal:  Cell Metab       Date:  2010-01       Impact factor: 27.287

10.  Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice.

Authors:  Alessandro Pocai; Paul E Carrington; Jennifer R Adams; Michael Wright; George Eiermann; Lan Zhu; Xiaobing Du; Aleksandr Petrov; Michael E Lassman; Guoqiang Jiang; Franklin Liu; Corey Miller; Laurie M Tota; Gaochao Zhou; Xiaoping Zhang; Michael M Sountis; Alessia Santoprete; Elena Capito'; Gary G Chicchi; Nancy Thornberry; Elisabetta Bianchi; Antonello Pessi; Donald J Marsh; Ranabir SinhaRoy
Journal:  Diabetes       Date:  2009-07-14       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.